Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.

Jones SP, Qazi N, Morelese J, Lebrecht D, Sutinen J, Yki-Jărvinen H, Back DJ, Pirmohamed M, Gazzard BG, Walker UA, Moyle GJ.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):565-72.

PMID:
16284533
[PubMed - indexed for MEDLINE]
2.

Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.

Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Chan JW, Harrigan PR, O'Shaughnessy MV.

J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S85-90. Review.

PMID:
14562863
[PubMed - indexed for MEDLINE]
3.

HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo.

Lagathu C, Kim M, Maachi M, Vigouroux C, Cervera P, Capeau J, Caron M, Bastard JP.

Biochimie. 2005 Jan;87(1):65-71. Review.

PMID:
15733739
[PubMed - indexed for MEDLINE]
4.

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.

Brinkman K, Smeitink JA, Romijn JA, Reiss P.

Lancet. 1999 Sep 25;354(9184):1112-5. Review.

PMID:
10509516
[PubMed - indexed for MEDLINE]
5.

[Tenofovir as a strategy to avoid or limit adverse effects].

Portilla J.

Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:19-24. Review. Spanish.

PMID:
19195434
[PubMed - indexed for MEDLINE]
6.

Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.

Barbaro G.

Curr Pharm Des. 2007;13(21):2208-13. Review.

PMID:
17627554
[PubMed - indexed for MEDLINE]
7.

Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation.

Feeney ER, Mallon PW.

Curr Pharm Des. 2010 Oct;16(30):3339-51. Review.

PMID:
20687890
[PubMed - indexed for MEDLINE]
8.

An introduction to nucleoside and nucleotide analogues.

Squires KE.

Antivir Ther. 2001;6 Suppl 3:1-14. Review.

PMID:
11678469
[PubMed - indexed for MEDLINE]
9.

Antiretroviral-therapy-associated lipoatrophy: current status and future directions.

Nolan D, Mallal S.

Sex Health. 2005;2(3):153-63. Review.

PMID:
16335543
[PubMed - indexed for MEDLINE]
10.

Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals.

Spaulding A, Rutherford GW, Siegfried N.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD008651. doi: 10.1002/14651858.CD008651. Review.

PMID:
20687097
[PubMed - indexed for MEDLINE]
11.

Mitochondria and HIV infection: the first decade.

Cossarizza A, Troiano L, Mussini C.

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):18-24. Review.

PMID:
12003168
[PubMed - indexed for MEDLINE]
12.

Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.

Gougeon ML, Pénicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J.

Antivir Ther. 2004 Apr;9(2):161-77. Review.

PMID:
15134178
[PubMed - indexed for MEDLINE]
13.

Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease.

Vigouroux C, Gharakhanian S, Salhi Y, Nguyên TH, Adda N, Rozenbaum W, Capeau J.

Diabetes Metab. 1999 Nov;25(5):383-92. Review.

PMID:
10592860
[PubMed - indexed for MEDLINE]
Free Article
14.

Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.

Joly V, Yeni P.

Antivir Ther. 2005;10(1):29-40. Review.

PMID:
15751761
[PubMed - indexed for MEDLINE]
15.
16.

[Pathogenic mechanisms for fat redistribution in patients with HIV disease].

Ion DA, Chivu LI, Chivu RD.

Rev Med Chir Soc Med Nat Iasi. 2006 Jul-Sep;110(3):657-61. Review. Romanian.

PMID:
17571562
[PubMed - indexed for MEDLINE]
17.

Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity.

Walker UA, Venhoff N.

Antivir Ther. 2005;10 Suppl 2:M117-23. Review.

PMID:
16152713
[PubMed - indexed for MEDLINE]
18.

Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.

Lewis W.

Antivir Ther. 2005;10 Suppl 2:M13-27. Review.

PMID:
16152703
[PubMed - indexed for MEDLINE]
19.

Antiretroviral activity of stavudine (2',3'-didehydro-3'-deoxythymidine, D4T).

Riddler SA, Anderson RE, Mellors JW.

Antiviral Res. 1995 Jun;27(3):189-203. Review.

PMID:
8540743
[PubMed - indexed for MEDLINE]
20.

The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.

Nolan D, Mallal S.

J HIV Ther. 2004 May;9(2):34-40. Review.

PMID:
15238874
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk